- Home
- NAGE vs LENZ Comparison
NAGE vs LENZ Comparison
Compare NAGE & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- LENZ
- Stock Information
- Founded
- NAGE 1999
- LENZ 2019
- Country
- NAGE United States
- LENZ United States
- Employees
- NAGE N/A
- LENZ N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- NAGE Health Care
- LENZ Health Care
- Exchange
- NAGE Nasdaq
- LENZ Nasdaq
- Market Cap
- NAGE 861.0M
- LENZ 819.1M
- IPO Year
- NAGE N/A
- LENZ 2021
- Fundamental
- Price
- NAGE $11.41
- LENZ $35.48
- Analyst Decision
- NAGE Strong Buy
- LENZ Strong Buy
- Analyst Count
- NAGE 3
- LENZ 5
- Target Price
- NAGE $16.67
- LENZ $41.80
- AVG Volume (30 Days)
- NAGE 1.0M
- LENZ 309.3K
- Earning Date
- NAGE 08-06-2025
- LENZ 05-07-2025
- Dividend Yield
- NAGE N/A
- LENZ N/A
- EPS Growth
- NAGE N/A
- LENZ N/A
- EPS
- NAGE 0.18
- LENZ N/A
- Revenue
- NAGE $107,925,000.00
- LENZ N/A
- Revenue This Year
- NAGE $26.44
- LENZ N/A
- Revenue Next Year
- NAGE $20.06
- LENZ $544.79
- P/E Ratio
- NAGE $63.14
- LENZ N/A
- Revenue Growth
- NAGE 29.77
- LENZ N/A
- 52 Week Low
- NAGE $2.52
- LENZ $16.54
- 52 Week High
- NAGE $14.69
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- LENZ 68.67
- Support Level
- NAGE N/A
- LENZ $31.01
- Resistance Level
- NAGE N/A
- LENZ $32.79
- Average True Range (ATR)
- NAGE 0.00
- LENZ 2.00
- MACD
- NAGE 0.00
- LENZ 0.48
- Stochastic Oscillator
- NAGE 0.00
- LENZ 93.76
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.